Article ID Journal Published Year Pages File Type
4137381 Pathophysiology 2009 6 Pages PDF
Abstract
Glucocorticoid (GC) hormones exert an antiproliferative effect on various cells. The effect is mainly mediated by glucocorticoid receptor (GR) which acts as a transcription factor. Ligand-bound GR translocates from the cytoplasm into the nucleus to modulate gene expression in a variety of ways. Although the framework of transcriptional regulation by the GC/GR has been described, the molecular mechanism of antiproliferative effect of GC is still largely unclear. In this article, we reviewed GC-induced changes in gene expression that are involved in GC-antiproliferative effect, and mainly focused on our recently identified glucocorticoid-responsive genes, TGF-β receptor type II (TβRII) and small GTP binding protein RhoB. We found that expressions of TβRII and RhoB were up-regulated by ligand-bound GR at mRNA and protein levels. Blocking the effect of TβRII by TβRII neutralizing antibody or reduction of RhoB mRNA expression by RNAi diminished dexamethasone-inhibitory effect on cell proliferation, thus confirming that these genes are involved in GC anti-proliferation effect. Collectively, GC up-regulating the expressions of RhoB and TβRII play an important role in GC anti-proliferation effect.
Related Topics
Health Sciences Medicine and Dentistry Pathology and Medical Technology
Authors
,